Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.92 USD | -3.43% | -3.24% | +18.83% |
May. 22 | Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing | MT |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.83% | 5.59B | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-2.82% | 21.58B | |
-8.12% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Halozyme Therapeutics Insider Sold Shares Worth $788,670, According to a Recent SEC Filing